drugset / Trial / NCT00501137

A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine

NCT00501137

RandomizedParallel-groupSingle-blindPrevention

Summary

Primary objective is to determine if antibody responses to HPV types 16 \& 18 are non-inferior after a 2-dose paediatric regimen as compared to a 3-dose adult regimen of Q-HPV vaccination, with responses measured at Month 7.

Timeline

Start
2007-07
Primary completion
2008-02
Completion
2010-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gardasil Vaccine